Generic Name : Taceva
Brand Name : Erlotinib
Manufacturer Name : Cipla India
Product Code : OBP 943
Delivery Days : 10 To 12 Working Days
Composition : Taceva
Strength : 100mg
Packaging : Tablet (Blisters)
Presentation : Bottle Pack
Drug Class : Antineoplastic
Prescribed For : Treatment of non-small cell lung cancer and pancreatic cancer
Side Effects : Stomach pain, Bone pain, Breathlessness, Constipation, Cough, Diarrhea, Loss of appetite
| Pack Size/Qty | Price | Price Per Pill or unit | |
| 60 TABLET'S | $281.40 | $4.69 | |
| 30 TABLET'S | $142.20 | $4.74 |
Erlocip 100 MG Tablet is a pharmaceutical medication used in the treatment of certain types of cancer. Each tablet contains erlotinib hydrochloride as the active ingredient, and it falls into the category of medications known as tyrosine kinase inhibitors. Erlotinib is designed to target specific signaling pathways in the body associated with the growth and survival of cancer cells.
Erlocip 100 MG Tablet operates by disrupting the activity of the epidermal growth factor receptor (EGFR), a key player in the regulation of cell growth. Here's how Erlocip works:
EGFR Inhibition:
EGFR is a cell surface receptor that, when activated, triggers signaling pathways within cells, promoting processes like cell growth and division. Abnormal activation of EGFR is often observed in certain types of cancer.
Tyrosine Kinase Inhibition:
The active ingredient in Erlocip, erlotinib hydrochloride, is classified as a tyrosine kinase inhibitor. This means it interferes with the enzymatic activity of tyrosine kinases associated with EGFR.
Blockage of Signaling Pathways:
By inhibiting tyrosine kinases, Erlocip disrupts the downstream signaling pathways activated by EGFR. These pathways are vital for regulating various cellular processes, and their aberrant activation is a hallmark of cancer.
Cell Growth Inhibition:
The disruption of signaling pathways leads to a decrease in abnormal cell growth and division. Erlocip specifically targets cancer cells that rely on these pathways for uncontrolled proliferation.
Apoptosis Induction:
Erlocip may induce apoptosis, a programmed cell death process. This is a natural mechanism by which damaged or abnormal cells are eliminated from the body.
Targeted Therapy:
Erlocip's mechanism of action is considered targeted therapy. It focuses on inhibiting EGFR, a specific molecular target implicated in cancer growth, while sparing normal, healthy cells as much as possible.
Cancer Types:
Erlocip is particularly effective in cancers where EGFR is overexpressed or mutated. It is commonly used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer.
Ingredients:
Erlocip 100 MG Tablets contain the active ingredient erlotinib hydrochloride. Each tablet typically contains 100 milligrams of erlotinib hydrochloride as the primary therapeutic component. In addition to the active ingredient, there may be inactive ingredients (excipients), but these are not usually specified in general information.
Dosage:
The standard dosage of Erlocip 100 MG Tablets is determined by healthcare professionals based on individual patient factors, including the type and stage of cancer. Patients are typically advised to take the prescribed dosage as directed by their healthcare providers. The tablets are usually taken orally, with a full glass of water.
Here are key considerations regarding who can use Erlocip 100 MG Tablets:
Non-Small Cell Lung Cancer (NSCLC):
Erlocip is commonly used in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). It is particularly beneficial in cases where there are specific genetic mutations or overexpression of the epidermal growth factor receptor (EGFR).
Pancreatic Cancer:
Erlocip is also indicated for the treatment of locally advanced, unresectable, or metastatic pancreatic cancer. It is used in combination with gemcitabine, another chemotherapy drug.
EGFR-Positive Cancers:
The decision to use Erlocip is often based on the presence of specific molecular characteristics, such as EGFR mutations or overexpression. Individuals with EGFR-positive cancers are more likely to benefit from the targeted therapy provided by Erlocip.
Individualized Treatment Plans:
The use of Erlocip is part of an individualized treatment plan developed by healthcare professionals. Factors such as the type and stage of cancer, genetic mutations, overall health, and patient preferences are taken into account.
Under Healthcare Supervision:
Erlocip is a prescription medication, and individuals using it should be under the care and supervision of experienced healthcare professionals. Regular monitoring and assessments are typically conducted to evaluate treatment effectiveness and manage potential side effects.
Comprehensive Medical History:
Individuals should provide a comprehensive medical history to their healthcare providers, including information about existing medical conditions, current medications, and any potential allergies. This information helps healthcare professionals assess the suitability of Erlocip for each patient.
Here are some key considerations to avoid:
Missed Doses:
Missing a dose of Erlocip can affect the consistency of the medication in your system. Try to adhere to the prescribed schedule, and if you do miss a dose, consult your healthcare provider for guidance.
Self-Adjusting Dosage:
Do not adjust the dosage of Erlocip on your own. Changes to the prescribed dosage should only be made under the guidance of your healthcare provider.
Incorrect Timing with Meals:
Erlocip is often taken on an empty stomach, either one hour before or two hours after meals. Adhering to these instructions ensures optimal absorption. Avoid taking it with food unless advised otherwise.
Crushing or Breaking Tablets:
Swallow Erlocip tablets whole with a full glass of water. Do not crush, break, or chew the tablets unless your healthcare provider specifically advises otherwise.
Inconsistent Timing:
Try to take Erlocip at the same time each day to maintain a consistent level of the medication in your body. Inconsistent timing can impact its effectiveness.
Failure to Stay Hydrated:
Diarrhea is a potential side effect of Erlocip. Ensure you stay well-hydrated unless otherwise advised by your healthcare provider. Seek medical attention if diarrhea persists.
Ignoring Side Effects:
Report any side effects to your healthcare provider promptly. Do not ignore symptoms such as skin rash, persistent diarrhea, or changes in overall well-being.
Discontinuing Treatment Without Consultation:
Do not stop taking Erlocip without consulting your healthcare provider. Abruptly discontinuing the medication can impact the effectiveness of your treatment.
Overlooking Regular Monitoring:
Regular check-ups and monitoring tests are essential during Erlocip treatment. Attend all scheduled appointments to assess treatment effectiveness and manage potential side effects.
Failure to Communicate with Healthcare Team:
Keep an open line of communication with your healthcare team. Inform them of any changes in your health, the development of new symptoms, or the use of additional medications.
Online Blue Pills is a leading online pharmacy for all your medical needs. If you want to shop Erlocip 100 MG Tablets online in the USA, Online Blue Pills is your go-to destination. Get medicines at the most affordable prices and quickly delivered across the USA only from Online Blue Pills.
What is Erlocip 100 MG Tablet used for?
Erlocip is used for the treatment of certain types of cancer, including non-small cell lung cancer (NSCLC) with specific genetic mutations and pancreatic cancer.
How does Erlocip 100 MG Tablet work?
Erlocip is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR), inhibiting abnormal cell growth in certain cancers.
What are the common side effects of Erlocip 100 MG Tablets?
Common side effects include skin rash, diarrhea, fatigue, nausea, vomiting, loss of appetite, dry skin, eye irritation, mouth sores, changes in liver function tests, and hair changes.
How should Erlocip 100 MG Tablets be taken?
Take Erlocip orally with a full glass of water. It is usually taken on an empty stomach, either one hour before or two hours after meals. Swallow the tablet whole without crushing or chewing.
What should I do if I miss a dose of Erlocip?
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not double up on doses. Consult your healthcare provider for guidance.
Can I adjust the dosage of Erlocip on my own?
No, do not adjust the dosage on your own. Any changes to the prescribed dosage should be made under the guidance of your healthcare provider.
How often will I be monitored during Erlocip treatment?
Regular check-ups and monitoring tests are typically conducted to assess treatment effectiveness and manage potential side effects. Follow your healthcare provider's schedule for monitoring.
Can I stop taking Erlocip if I feel better?
No, do not stop taking Erlocip without consulting your healthcare provider. Abruptly discontinuing the medication can impact the effectiveness of your treatment.
Is it safe to use Erlocip during pregnancy or breastfeeding?
Discuss pregnancy or breastfeeding plans with your healthcare provider. Erlocip may pose risks, and a thorough evaluation of benefits and risks is essential.
What should I do if I experience severe side effects?
If you experience severe side effects or any signs of an allergic reaction, seek immediate medical attention. Report all side effects promptly to your healthcare provider.
Common side effects associated with Erlocip 100 MG Tablets may include:
Skin Rash:
Skin rash is a common side effect of Erlocip. It may manifest as redness, itching, or acne-like eruptions. Notify your healthcare provider if a rash develops.
Diarrhea:
Diarrhea is another common side effect. Maintain hydration and inform your healthcare team if diarrhea persists or becomes severe.
Fatigue:
Feeling tired or fatigued is a common occurrence. Adequate rest and proper nutrition can help manage fatigue.
Nausea and Vomiting:
Some individuals may experience nausea and vomiting. Inform your healthcare provider if these symptoms are persistent or severe.
Loss of Appetite:
A decrease in appetite may occur. Discuss any significant changes in eating habits with your healthcare team.
Infections:
Erlocip may increase the risk of infections. Report any signs of infection, such as fever or persistent cough, to your healthcare provider.
Dry Skin:
Dryness, itching, or peeling of the skin may occur. Use a mild moisturizer and inform your healthcare provider if skin issues become bothersome.
Eye Irritation:
Irritation of the eyes, including redness or dryness, can occur. Inform your healthcare team if eye symptoms persist.
Mouth Sores:
Some individuals may experience mouth sores. Maintain good oral hygiene, and notify your healthcare provider if mouth sores are a concern.
Changes in Liver Function Tests:
Erlocip can impact liver function. Regular monitoring of liver function tests is typically conducted by healthcare professionals.
Hair Changes:
Changes in hair color or texture may occur. Hair may become thinner or more brittle.
Here are the key uses of Erlocip 100 MG Tablets:
Non-Small Cell Lung Cancer (NSCLC):
Erlocip is prescribed for the treatment of advanced or metastatic non-small cell lung cancer, particularly in cases where there are specific genetic mutations or overexpression of the epidermal growth factor receptor (EGFR). It is used as part of a comprehensive treatment plan for NSCLC.
Pancreatic Cancer:
Erlocip is indicated for the treatment of locally advanced, unresectable, or metastatic pancreatic cancer. It is often used in combination with gemcitabine, another chemotherapy drug. This combination therapy aims to improve treatment outcomes for individuals with pancreatic cancer.
Targeted Therapy:
Erlocip belongs to the class of drugs known as tyrosine kinase inhibitors. Its mechanism of action involves specifically targeting and inhibiting the activity of the EGFR, a protein involved in regulating cell growth. This targeted approach distinguishes Erlocip from traditional chemotherapy.
EGFR-Positive Cancers:
The use of Erlocip is particularly effective in cancers where there is an overexpression or abnormal activation of EGFR. By inhibiting EGFR, Erlocip works to inhibit the abnormal growth and division of cancer cells.
Here are general instructions on how to use Erlocip:
Prescription and Consultation:
Erlocip 100 MG Tablets are prescription medications. Use them only as directed by your healthcare provider. The decision to prescribe Erlocip is based on individual factors such as the type and stage of cancer.
Dosage and Schedule:
Take the tablets exactly as prescribed by your healthcare professional. The recommended dosage and administration schedule depend on individual factors, and adjustments may be made based on your response to treatment.
Oral Administration:
Erlocip is taken orally, usually with a full glass of water. Swallow the tablet whole without crushing, breaking, or chewing it. If you have difficulty swallowing, discuss alternative options with your healthcare provider.
Timing with Meals:
Erlocip is typically taken on an empty stomach, either one hour before or two hours after meals. Follow your healthcare provider's instructions regarding food restrictions around the time of administration.
Consistent Timing:
Try to take Erlocip at the same time each day to maintain a consistent level of the medication in your body. This helps optimize its effectiveness.
Missed Dose:
If you miss a dose, take it as soon as you remember, unless it is close to the time for your next scheduled dose. Do not double up on doses to make up for a missed one. Consult your healthcare provider for guidance on missed doses.
Regular Monitoring:
Your healthcare provider may conduct regular check-ups and tests to monitor the effectiveness of the treatment and manage potential side effects. Attend all scheduled appointments.
Hydration:
Stay well-hydrated unless otherwise advised by your healthcare provider. Adequate hydration is important, especially if you experience diarrhea.
Adherence to Medical Advice:
Follow all additional instructions and recommendations provided by your healthcare team. Report any side effects or concerns promptly.
Comprehensive Medical History:
Inform your healthcare provider about your complete medical history, including existing medical conditions, current medications, and any allergies. This information helps healthcare professionals assess the suitability of Erlocip for each patient.
The information provided on website is intended for educational purposes only and should not be used as a substitute for professional medical advice. Please consult a qualified healthcare professional for personalized medical advice.
with branches throughout the USA
Your information is in safe hands.
on all standard USA orders over $ 250
